• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by Morgan Stanley

    7/1/25 9:08:05 AM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance
    Get the next $MS alert in real time by email
    FWP 1 ms9091_fwp-19523.htm FREE WRITING PROSPECTUS TO PRELIMINARY PRICING SUPPLEMENT NO. 9,091

    Free Writing Prospectus to Preliminary Pricing Supplement No. 9,091

    Registration Statement Nos. 333-275587; 333-275587-01

    Dated July 1, 2025; Filed pursuant to Rule 433

    Morgan Stanley

    Worst-of INDU, NDX and RTY Callable Contingent Income Securities due August 2, 2028

    This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.

    Terms

    Issuer:

    Morgan Stanley Finance LLC

    Guarantor:

    Morgan Stanley

    Underliers:

    Dow Jones Industrial AverageSM (INDU), Nasdaq-100 Index® (NDX) and Russell 2000® Index (RTY)

    Call feature:

    Quarterly, based on the output of a risk neutral valuation model. See the accompanying preliminary pricing supplement.

    Redemption dates:

    Beginning after 6 months, quarterly

    Contingent coupon:

    7.00% to 8.00% per annum

    Coupon payment dates:

    Quarterly

    Coupon barrier level:

    70% of the initial level for each underlier

    Downside threshold level:

    70% of the initial level for each underlier

    Pricing date:

    July 28, 2025

    Final observation date:

    July 28, 2028

    Maturity date:

    August 2, 2028

    CUSIP:

    61778NCT6

    Estimated value:

    $935.10 per security, or within $45.00 of that estimate

    Preliminary pricing supplement:

    https://www.sec.gov/Archives/edgar/data/895421/000183988225035854/ms9091_424b2-19522.htm

    1All payments are subject to our credit risk

     

    Hypothetical Payment at Maturity1

    (if the securities have not been redeemed)

    % Change in Closing Level of the Worst Performing Underlier

    Payment at Maturity per Security (excluding any contingent coupon payable at maturity)

    +100.00%

    $1,000.00

    +80.00%

    $1,000.00

    +60.00%

    $1,000.00

    +40.00%

    $1,000.00

    +20.00%

    $1,000.00

    0.00%

    $1,000.00

    -20.00%

    $1,000.00

    -30.00%

    $1,000.00

    -31.00%

    $690.00

    -40.00%

    $600.00

    -60.00%

    $400.00

    -80.00%

    $200.00

    -100.00%

    $0.00

     

     

    The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

    Underlier(s)

    For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

    Risk Considerations

    The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

    Risks Relating to an Investment in the Securities

    ●The securities do not guarantee the return of any principal.

    ●The securities do not provide for the regular payment of interest.

    ●Payment of the contingent coupon is based on the closing levels of the underliers on only the related observation date at the end of the related interest period.

    ●Investors will not participate in any appreciation in the value of any underlier.

    ●The securities are subject to early redemption risk.

    ●The market price of the securities may be influenced by many unpredictable factors.

    ●The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

    ●As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

    ●The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

    ●The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

    ●The securities will not be listed on any securities exchange and secondary trading may be limited.

    ●As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

    ●The U.S. federal income tax consequences of an investment in the securities are uncertain.

    Risks Relating to the Underlier(s)

    ●Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

    oYou are exposed to the price risk of each underlier.

    oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a significant loss on your investment than if the securities were linked to just one underlier.

    oAdjustments to an underlying index could adversely affect the value of the securities.

    ●The securities are subject to risks associated with small-capitalization companies.

    Risks Relating to Conflicts of Interest

    ●The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

    ●Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

    Tax Considerations

    You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities–United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

     

    Get the next $MS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MS

    DatePrice TargetRatingAnalyst
    11/26/2024Buy → Hold
    HSBC Securities
    11/15/2024$142.00Underweight → Equal Weight
    Wells Fargo
    10/4/2024$118.00Hold → Buy
    HSBC Securities
    9/11/2024Buy → Neutral
    Goldman
    8/2/2024$99.00 → $95.00Equal Weight → Underweight
    Wells Fargo
    7/17/2024Outperform → Perform
    Oppenheimer
    1/17/2024$94.00 → $87.00Overweight → Neutral
    JP Morgan
    1/17/2024$102.00 → $91.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $MS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program

      Morgan Stanley (NYSE:MS) announced that it will increase its quarterly common stock dividend to $1.00 per share from the current $0.925 per share, beginning with the common stock dividend expected to be declared by the Firm's Board of Directors in the third quarter of 2025. In addition, the Firm's Board of Directors reauthorized a multi-year common equity share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter of 2025. The share repurchases will be exercised from time to time at prices the Firm deems appropriate, subject to various considerations, including current market conditions, the Firm's capital position and future economic and e

      7/1/25 4:36:00 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

      The Eaton Vance closed-end funds listed below released today the estimated sources of their June distributions (each a "Fund"). This press release is issued as required by the Funds' managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the June distribution. It is not determinative of the tax character of a Fund's distributions for the 2025

      6/30/25 4:00:00 PM ET
      $EOI
      $EOS
      $ETB
      $ETG
      Finance/Investors Services
      Finance
      Trusts Except Educational Religious and Charitable
      Investment Bankers/Brokers/Service
    • Morgan Stanley Wins Two 2025 Celent Model Wealth Manager Awards for Technology Innovation in Wealth Management

      Morgan Stanley (NYSE:MS) announced today that it has won two 2025 Celent Model Awards recognizing the Firm's innovative use of technology. The Firm secured Model Wealth Manager Awards for its SMA Matching and Transition Analysis Tools in the Data and Analytics category and for its AI @ Morgan Stanley Debrief in the Emerging Technologies category. "As our teams are continuously innovating and sourcing technology to push the industry forward, it's an honor to be recognized by Celent," said Jed Finn, Head of Morgan Stanley Wealth Management. "These awards validate our commitment to leverage technology to build a differentiated platform for our Financial Advisors that helps them grow their pr

      6/30/25 11:00:00 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance

    $MS
    SEC Filings

    See more
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 4:53:42 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 4:52:06 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Morgan Stanley filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - MORGAN STANLEY (0000895421) (Filer)

      7/1/25 4:49:58 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance

    $MS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley downgraded by HSBC Securities

      HSBC Securities downgraded Morgan Stanley from Buy to Hold

      11/26/24 7:38:24 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Morgan Stanley upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Morgan Stanley from Underweight to Equal Weight and set a new price target of $142.00

      11/15/24 8:38:28 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Morgan Stanley upgraded by HSBC Securities with a new price target

      HSBC Securities upgraded Morgan Stanley from Hold to Buy and set a new price target of $118.00

      10/4/24 7:44:51 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance

    $MS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Leibowitz Shelley B was granted 2,155 shares, increasing direct ownership by 5% to 48,614 units (SEC Form 4)

      4 - MORGAN STANLEY (0000895421) (Issuer)

      6/3/25 4:09:40 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Director Nally Dennis M was granted 2,155 shares, increasing direct ownership by 5% to 44,385 units (SEC Form 4)

      4 - MORGAN STANLEY (0000895421) (Issuer)

      6/3/25 4:09:28 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Director Butler Megan was granted 2,155 shares and covered exercise/tax liability with 286 shares, increasing direct ownership by 68% to 4,624 units (SEC Form 4)

      4 - MORGAN STANLEY (0000895421) (Issuer)

      6/3/25 4:09:15 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance